Tagrisso
Osimertinib · AstraZeneca Pharmaceuticals LP
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Tagrisso ingredients
| Active ingredient | Strength |
|---|---|
| Osimertinib | 80 mg/1, 40 mg/1 |
What Tagrisso is used for
Tagrisso is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Tagrisso
- Generic name
- Osimertinib
- Made by
- AstraZeneca Pharmaceuticals LP
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA208065
- On the US market since
- 2015
Official information
- MedlinePlus drug information (search for Osimertinib)
In India
- Osimertinib: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tagrisso?
Tagrisso (Osimertinib) is a cancer medicine made by AstraZeneca Pharmaceuticals LP, approved by the US FDA.
What are the ingredients of Tagrisso?
Tagrisso contains Osimertinib (80 mg/1, 40 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA